|
⚲
|
| Keyboard |
| Bruns Ingmar
✚
|
|
|---|---|
| CIK # | 0001838041 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001838041] | |
| 4 | [0001838041] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bruns Ingmar | |
| Zentalis Pharmaceuticals Inc | |
| Trillium Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2026-02-09 | Sell | 335 | $2.39 | 801 |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2026-02-06 | Sell | 2,962 | $2.43 | 7,198 |
|
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
|
2026-01-08 | Grant | 365,000 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2025-02-06 | Buy | 20,000 | $2.28 | 45,600 |
|
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
|
2025-02-03 | Grant | 16,629 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2025-02-03 | Grant | 16,629 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Stock Option (Right to Buy) · derivative
|
2024-12-02 | Grant | 712,650 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-11-17 | Disposed to issuer | 400,000 | $0.00 |